U.S. National Institutes of Health·United States of America
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites research grant applications for the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain. The goal is to provide the requisite data needed to advance promising PET ligands for use in clinical research.
Key aspects of this opportunity include:
• Development and application of PET and SPECT imaging ligands as biomarkers for drug discovery and for pathophysiological studies of CNS disorders
• Incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies
• Expected application count is 100, with an expected application size of 0
• Electronic submission is required
You found this one too late. Don't find the next one too late.
Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.